Acciones Wildflower Marijuana Inc Canadian Securities Exchange
Acciones
CA96812E1051
Farmacéuticos
Ventas 2018 | 1,41 1,92 1,3 | Ventas 2019 | 7,09 9,68 6,53 | Capitalización | 63,9 M 87,31 M 58,92 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -7 M -9,56 M -6,45 M | Resultado Neto 2019 | -4 M -5,47 M -3,69 M | VE / Ventas 2018 | 44.908.398 x |
Deuda neta 2018 | 7,85 M 10,73 M 7,24 M | Deuda neta 2019 | 7,32 M 10 M 6,75 M | VE / Ventas 2019 | 10.051.719 x |
P/E ratio 2018 |
-6,99
x | P/E ratio 2019 |
-6,61
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
William MacLean
CEO | Chief Executive Officer | - | 18/06/14 |
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30/08/13 |
Myron van Snick
COO | Chief Operating Officer | - | 13/04/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30/08/13 |
William MacLean
CEO | Chief Executive Officer | - | 18/06/14 |
Director/Board Member | - | 06/04/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+37,65 % | 6036,7 M | |
-19,68 % | 4274,63 M | |
+4,49 % | 3276,01 M | |
-15,69 % | 2960,13 M | |
-5,64 % | 2427,78 M | |
+44,89 % | 1930,32 M | |
-12,71 % | 1592,37 M | |
-4,27 % | 1576,11 M | |
-14,86 % | 1497,45 M |